DE19802792A1 - Hemmung der durch mutiertes p53 verursachten Modulation von DNA - Google Patents

Hemmung der durch mutiertes p53 verursachten Modulation von DNA

Info

Publication number
DE19802792A1
DE19802792A1 DE19802792A DE19802792A DE19802792A1 DE 19802792 A1 DE19802792 A1 DE 19802792A1 DE 19802792 A DE19802792 A DE 19802792A DE 19802792 A DE19802792 A DE 19802792A DE 19802792 A1 DE19802792 A1 DE 19802792A1
Authority
DE
Germany
Prior art keywords
dna
mut
strand separation
mutated
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19802792A
Other languages
German (de)
English (en)
Inventor
Wolfgang Willi Prof Dr Deppert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19802792A priority Critical patent/DE19802792A1/de
Priority to JP2000528710A priority patent/JP2002507389A/ja
Priority to PL99342399A priority patent/PL342399A1/xx
Priority to PCT/DE1999/000221 priority patent/WO1999037803A2/de
Priority to RU2000121564/13A priority patent/RU2235786C2/ru
Priority to CN99802374A priority patent/CN1289373A/zh
Priority to SK1105-2000A priority patent/SK11052000A3/sk
Priority to EP99910089A priority patent/EP1049810A2/de
Priority to BR9907725-6A priority patent/BR9907725A/pt
Priority to KR10-2000-7008117A priority patent/KR100413929B1/ko
Priority to CA002318313A priority patent/CA2318313A1/en
Priority to DE19980080T priority patent/DE19980080D2/de
Priority to AU29200/99A priority patent/AU755775B2/en
Publication of DE19802792A1 publication Critical patent/DE19802792A1/de
Priority to NO20003762A priority patent/NO20003762D0/no
Priority to US10/890,433 priority patent/US20050070495A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE19802792A 1998-01-26 1998-01-26 Hemmung der durch mutiertes p53 verursachten Modulation von DNA Withdrawn DE19802792A1 (de)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DE19802792A DE19802792A1 (de) 1998-01-26 1998-01-26 Hemmung der durch mutiertes p53 verursachten Modulation von DNA
EP99910089A EP1049810A2 (de) 1998-01-26 1999-01-22 HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA
BR9907725-6A BR9907725A (pt) 1998-01-26 1999-01-22 Inibição de modulação de dna provocada por p53 mutado
PCT/DE1999/000221 WO1999037803A2 (de) 1998-01-26 1999-01-22 HEMMUNG DER DURCH MUTIERTES p53 VERURSACHTEN MODULATION VON DNA
RU2000121564/13A RU2235786C2 (ru) 1998-01-26 1999-01-22 Способ подавления модуляции днк, набор
CN99802374A CN1289373A (zh) 1998-01-26 1999-01-22 对由突变的p53导致的DNA调制的抑制
SK1105-2000A SK11052000A3 (sk) 1998-01-26 1999-01-22 Inhibícia modulácie dna spôsobenej mutovaným p53
JP2000528710A JP2002507389A (ja) 1998-01-26 1999-01-22 変異ｐ５３によって引き起こされるＤＮＡモジュレーションの阻害
PL99342399A PL342399A1 (en) 1998-01-26 1999-01-22 Inhibition of dna modulation caused by mutated p53
KR10-2000-7008117A KR100413929B1 (ko) 1998-01-26 1999-01-22 돌연변이 피53에 의해 유발되는 디앤에이 변성의 억제방법
CA002318313A CA2318313A1 (en) 1998-01-26 1999-01-22 Inhibition of dna modulation caused by mutated p53
DE19980080T DE19980080D2 (de) 1998-01-26 1999-01-22 Hemmung der durch mutiertes p53 verursachten Modulation von DNA
AU29200/99A AU755775B2 (en) 1998-01-26 1999-01-22 Inhibition of DNA modulation caused by mutated p53
NO20003762A NO20003762D0 (no) 1998-01-26 2000-07-21 Inhibering av DNA-modulering forÕrsaket av mutert p53
US10/890,433 US20050070495A1 (en) 1998-01-26 2003-04-22 Inhibition of DNA modulation caused by mutated p53

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19802792A DE19802792A1 (de) 1998-01-26 1998-01-26 Hemmung der durch mutiertes p53 verursachten Modulation von DNA

Publications (1)

Publication Number Publication Date
DE19802792A1 true DE19802792A1 (de) 1999-07-29

Family

ID=7855657

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19802792A Withdrawn DE19802792A1 (de) 1998-01-26 1998-01-26 Hemmung der durch mutiertes p53 verursachten Modulation von DNA
DE19980080T Ceased DE19980080D2 (de) 1998-01-26 1999-01-22 Hemmung der durch mutiertes p53 verursachten Modulation von DNA

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19980080T Ceased DE19980080D2 (de) 1998-01-26 1999-01-22 Hemmung der durch mutiertes p53 verursachten Modulation von DNA

Country Status (13)

Country Link
EP (1) EP1049810A2 (no)
JP (1) JP2002507389A (no)
KR (1) KR100413929B1 (no)
CN (1) CN1289373A (no)
AU (1) AU755775B2 (no)
BR (1) BR9907725A (no)
CA (1) CA2318313A1 (no)
DE (2) DE19802792A1 (no)
NO (1) NO20003762D0 (no)
PL (1) PL342399A1 (no)
RU (1) RU2235786C2 (no)
SK (1) SK11052000A3 (no)
WO (1) WO1999037803A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348113C (zh) * 2005-05-14 2007-11-14 章建庆 一种食用籼草鱼的制作方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224784D0 (en) * 1992-11-26 1993-01-13 Univ Dundee Cellular protein
GB9521544D0 (en) * 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof

Also Published As

Publication number Publication date
NO20003762L (no) 2000-07-21
KR100413929B1 (ko) 2004-01-07
BR9907725A (pt) 2001-09-04
WO1999037803A3 (de) 1999-10-14
EP1049810A2 (de) 2000-11-08
SK11052000A3 (sk) 2001-05-10
NO20003762D0 (no) 2000-07-21
DE19980080D2 (de) 2001-03-29
CN1289373A (zh) 2001-03-28
CA2318313A1 (en) 1999-07-29
WO1999037803A2 (de) 1999-07-29
KR20010040407A (ko) 2001-05-15
WO1999037803A9 (de) 1999-11-18
AU2920099A (en) 1999-08-09
RU2235786C2 (ru) 2004-09-10
PL342399A1 (en) 2001-06-04
JP2002507389A (ja) 2002-03-12
AU755775B2 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
DE3043981C2 (no)
DE3650416T2 (de) Zelluläres verfahren zur bestimmung des originalen gewebes.
DE3751307T2 (de) Zubereitungen und verfahren für klone, die, mit mehrfacharzneimittelresistenz assoziierte, dna-sequenzen in menschlichen zellen enthalten.
DE19824230A1 (de) Neues Endometriose-assoziiertes Gen
DE19802792A1 (de) Hemmung der durch mutiertes p53 verursachten Modulation von DNA
DE3789883T2 (de) Nukleare faktoren, die mit der regulierung der transkription assoziiert sind.
EP1588172A2 (de) Verfahren zur identifizierung bhs-spezifischer proteine und fragmente davon
DE68925369T3 (de) Klonierung von methylierter DNS in einem bakteriellen Wirtsstamm der zur Wirtsrestriktion unfähig ist
EP1015037B1 (de) BEEINFLUSSUNG DER BINDUNG VON p53 AN ZIELGENE
DE4330307C2 (de) Verwendung von Nukleinsäuregelelektrophorese zur Identifizierung von Organismenteilen und dergleichen
EP1097209B1 (de) Hemmung von alopezie
DE19633427A1 (de) Verfahren zur Synthese von Nukleinsäuremolekülen mit zumindest teilweise vorbestimmter Nukleotidsequenz
DE19736198C1 (de) Protease-verwandtes Protein
EP0449178A2 (de) Verfahren zur Verminderung von Sternaktivitäten
DE19544333C2 (de) Verfahren zur Beurteilung der Aktivität von Arzneistoffen
DE69107662T2 (de) Verfahren zum Determinieren der Hybridqualität von Samen.
EP1086220A2 (de) Gdnf-kodierende dna, teile davon und gdnf-varianten
DE69404370T2 (de) Gelatinase A zur Behandlung von der Alzheimerschen Krankheit
DE69735636T2 (de) Verfahren zur bestimmung des malignen zellezustands und verfahren zur behandlung
DE4422259C2 (de) Anti-Sinn-Oligonukleotide zur Aromatase-Inhibierung
DE19856301C1 (de) Regulatorisches Protein pKe#83 aus humanen Keratinozyten
EP0017785A2 (de) Seminalplasmin, Verfahren zu seiner Herstellung und seine Verwendung
DE19840875A1 (de) Mittel zur Diagnose und zur Therapie von Tumorerkrankungen
EP0449170A1 (de) Zelluläres Bindungsprotein mit Affinität für die regulatorische Region des menschlichen Papillomavirus Typ 18
DE19932890A1 (de) DNA zum Nachweis von Veränderungen des Chromosoms 8

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8143 Lapsed due to claiming internal priority